Trial Profile
Randomized trial for the efficacy of primary prophylaxis with granulocyte colony stimulating factor in advanced childhood mature B-cell malignancies.
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 22 Apr 2011
Price :
$35
*
At a glance
- Drugs Lenograstim (Primary)
- Indications Febrile neutropenia
- Focus Therapeutic Use
- 22 Dec 2009 Additional lead trial centre identified as reported by University Hospital Medical Information Network (Japan) record.
- 25 Aug 2009 New trial record